» Articles » PMID: 1534087

Molecular Characterization of the Stretch-induced Adaptation of Cultured Cardiac Cells. An in Vitro Model of Load-induced Cardiac Hypertrophy

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1992 May 25
PMID 1534087
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Although it is a well-known fact that hemodynamic load is a major determinant of cardiac muscle mass and its phenotype, little is known as to how mechanical load is converted into intracellular signals of gene regulation. To address this question, we characterized the stretch-induced adaptation of cultured neonatal cardiocytes grown on a stretchable substrate in a serum-free medium. Static stretch (20%) of the cells was applied without cell injury. Stretch caused hypertrophy in myocytes and hyperplasia in non-myocytes. Stretch caused an induction of immediate-early genes such as c-fos, c-jun, c-myc, JE, and Egr-1, but not Hsp70. Immunostaining showed that the stretch-induced Fos protein localized in the nucleus of both myocytes and non-myocytes. Nuclear extracts from stretched myocytes contained DNA binding activity to the AP-1 and Egr-1 consensus sequences. In myocytes, the induction of immediate-early genes was followed by expression of "fetal" genes such as skeletal alpha-actin, atrial natriuretic factor, and beta-myosin heavy chain. DNA transfection experiments showed that the "stretch-response element" of the c-fos gene promoter is present within 356 base pairs of the 5'-flanking region, whereas that of the atrial natriuretic factor and the beta-myosin heavy chain genes is probably located outside of 3412 and 628 base pairs of the 5'-flanking region, respectively. These results demonstrate that the phenotype of stretched cardiocytes in this in vitro model closely mimics that of hemodynamic load-induced hypertrophy in vivo. This model seems to be a suitable system with which to dissect the molecular mechanisms of load-induced hypertrophy of cardiac muscle.

Citing Articles

Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples.

Hu Y, Zou Y, Qiao L, Lin L Mol Ther. 2024; 32(10):3288-3312.

PMID: 39233439 PMC: 11489546. DOI: 10.1016/j.ymthe.2024.08.030.


Cannabinoid receptor agonist attenuates angiotensin II-induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes.

Altieri D, Etzion Y, Anderson H Front Pharmacol. 2023; 14:1142583.

PMID: 37113758 PMC: 10126395. DOI: 10.3389/fphar.2023.1142583.


Mechanotransduction for Muscle Protein Synthesis via Mechanically Activated Ion Channels.

Mirzoev T Life (Basel). 2023; 13(2).

PMID: 36836698 PMC: 9962945. DOI: 10.3390/life13020341.


The Protective Effects of miR-21-Mediated Fibroblast Growth Factor 1 in Rats with Coronary Heart Disease.

Zhang B, Liu H, Yang G, Wang Y, Wang Y Biomed Res Int. 2021; 2021:3621259.

PMID: 34901270 PMC: 8654569. DOI: 10.1155/2021/3621259.


Integrated Quantitative Phosphoproteomics and Cell-based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-related Phosphorylation Sites.

Kwon H, Choi H, Park S, Park W, Kim D, Park Z Mol Cells. 2021; 44(7):500-516.

PMID: 34158421 PMC: 8334354. DOI: 10.14348/molcells.2021.4002.